Introducing the investors participating in the panel

Investors in the Medicon Village Investor Panel

Bengt Julander – Linc
Bengt Julander is the Chairman and founder of the publicly listed investment company Linc, considered one of Sweden’s most renowned investors in Life Science. He has had a long career in the pharmaceutical industry and co-founded Calliditas Therapeutics – a company recently sold for approximately SEK 12 billion. Under Julander’s leadership, Linc has built a strong portfolio of life science companies. He is known for his deep industry knowledge and successful investments that drive the development of new treatments.

Erika Henriksson – EQT
Erika Henriksson is a partner at the private equity firm EQT, responsible for investments in life science and healthcare across Europe. She has been with EQT since 2007 and has played a key role in the firm’s journey to becoming one of the largest private equity firms in the world. Over the years, she has been involved in several EQT investments, including Karo Healthcare and the buyout of Recipharm from Nasdaq. Erika has a background in corporate finance at SEB Enskilda and holds a degree in business from the Stockholm School of Economics. Her long experience and strategic expertise make her a prominent healthcare investor.

Elin Almstedt – Navigare Ventures
Elin Almstedt is a Principal at Navigare Ventures – the Wallenberg family’s venture investment firm focused on Life Science. She is a prominent investor with experience in both the pharmaceutical industry (e.g., Sobi) and innovation support (as a business coach at Karolinska Institutet Innovations). At Navigare Ventures, she leads investments in promising startups across the Life Science spectrum. Elin holds a Master’s in Medical Science and a PhD in Neuro-oncology from Uppsala University, giving her a unique combination of scientific and commercial expertise.

Hugo Mörse – Bonit Capital / Leksell Social
Hugo Mörse is a partner at Bonit Capital and Managing Director of Leksell Social Ventures, through which the Leksell family invests its capital. The Leksell family, known for founding the medical technology company Elekta, is among Sweden’s most respected players in Life Science. Hugo leads the family’s investments both commercially (via Bonit Capital) and socially (via Leksell Social Ventures). With significant resources behind him, he focuses on supporting innovative companies and projects in the health sector, in line with his long-term commitment to medical advancement and societal benefit.

Christer Fåhraeus – Fåhraeus Startup & Growth
Christer Fåhraeus is a serial entrepreneur and the founder and General Partner of Fåhraeus Startup & Growth (FSG), a venture fund focused on early-stage life science and tech companies. He has over thirty years of experience building and leading high-growth ventures in these sectors. Fåhraeus founded and scaled multiple successful companies, including the medtech innovator CellaVision and the generic pharmaceutical firm EQL Pharma – both of which later went public. In addition to leading FSG’s investments, he has held numerous board and executive roles. Fåhraeus combination of deep scientific training (Ph.D. in neurophysiology) and entrepreneurial success makes him a prominent figure in Scandinavian life science innovation and venture investing..

Maria Tell – Segulah Medical Acceleration
Maria Tell is COO and Investment Director at Segulah Medical Acceleration – Segulah’s specialized investment platform in Life Science. With approximately 20 years of experience in investments and business development in medtech and biotech, she brings both strategic and operational expertise. She has previously worked at GE Healthcare Life Sciences, served as Investment Manager at Almi Invest, and was Marketing Director at the medtech company SyntheticMR – experience that has given her a broad industry perspective. At Segulah Medical, she leads investments in promising medical innovations and supports portfolio companies in accelerating their market development.

Lovisa Backemar – Eir Ventures
Lovisa Backemar is a partner at Eir Ventures, a venture capital fund investing in Life Science. She is a medical doctor with a PhD in clinical epidemiology from Karolinska Institutet. Lovisa has also worked as a management consultant at Boston Consulting Group, focusing on strategic projects in the pharmaceutical and healthcare sectors. Since joining Eir Ventures in 2023, she has played a central role in the team, where her combination of medical and analytical expertise contributes to identifying and supporting innovative Life Science companies.

Sebastian Hodel – Gainbridge Capital Partners
Sebastian Hodel Fryzell is Managing Partner at Gainbridge Capital Partners, an active investor focusing on entrepreneur-led growth companies. Sebastian has a technical background and over ten years of experience in the financial industry, including as COO of one of Sweden’s leading corporate finance advisors. He brings extensive experience as both an active investor and entrepreneur and has participated in over a hundred transactions as an advisor to growth companies, especially within Life Science.

Andreas Grape – Nordic Angels
Andreas Grape is co-founder and CEO of Nordic Angels, the Nordic region’s largest angel investor network. He has been a driving force in Stockholm’s startup ecosystem for over 20 years and previously founded the consultancy firm One Agency, which was sold in 2021. As an active angel investor and advisor, he provides valuable guidance to large parts of Sweden’s startup sector. Through Nordic Angels, he has created a platform where investors collaborate with high trust and mobilize capital for promising startups – an initiative that has established the network as a key player in early-stage funding in the region.

Ann-Charlotte Beckman – Life Science Invest
Ann-Charlotte Beckman is a serial entrepreneur and investor with over 30 years of experience in Life Science. Among other achievements, she helped launch Viagra in Sweden, served as CEO of Netdoktor (sold to Bonnier), and built up Bonnier Healthcare. Ann-Charlotte is also the founder of Life Science Invest – a network of over 100 angel investors focused on early-stage Nordic companies in digital health, pharmaceuticals, and medtech. She holds several board positions and is a recurring figure in the HealthTech investment landscape.

Johan Kördel – Sound Bioventures
Johan Kördel is Co-founder and Managing Partner at Sound Bioventures, a venture fund investing in private pharmaceutical companies. He has over two decades of experience in the pharmaceutical industry and was a co-founder of Biovitrum (now Sobi), where he led business development and research. Johan also spent ten years at Pharmacia, navigating several major mergers, which gave him deep industry insight. Prior to Sound Bioventures, he served as a Senior Partner at Lundbeckfonden Ventures for twelve years, where he invested in and served on the boards of several successful biotech companies. His combination of scientific expertise (Ph.D.) and investment success makes him a prominent figure in Life Science investing.

The coordinator of the Medicon Village Investor Panel

Markus Neuding is a former lawyer and seasoned entrepreneur with a background as Executive Vice President of Spotlight Group. He recently acquired Sedermera Corporate Finance, one of the Nordic region’s most active advisory firms within capital raising and M&A for growth companies, where he now serves as owner and principal. Markus has founded and built several companies and brings deep expertise in entrepreneurship, business development, and exits. As the coordinator of the Medicon Village Investment Panel, he also serves as a permanent member of the panel.